logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Kazuki Nishimura

osaka medical and pharmaceutical university
H指数:15
被引数:684

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

REAL-WORLD OUTCOMES OF IO-BASED FIRST-LINE THERAPY IN METASTATIC RENAL CELL CARCINOMA PATIENTS ON HEMODIALYSIS

IO-Based一线疗法在行血液透析的转移性肾细胞癌患者中的真实世界疗效

Journal of Urology
IF6.8
2026-05-010
PRE
Takahashi, Hidetsugu; Yanagisawa, Takafumi; Okamoto, Maria; Fukuokaya, Wataru; Urabe, Fumihiko; Mori, Keiichiro; Murakami, Masaya; Kawada, Tatsushi; Katayama, Satoshi; Yamanoi, Tomoaki; Bekku, Kensuke; Uchimoto, Taizo; Tsujino, Takuya; Nishimura, Kazuki; Maenosono, Ryoichi; Adachi, Takahiro; Hashimoto, Takeshi; Toyoda, Shingo; Nukaya, Takuhisa; Morinaka, Hirofumi; Tamura, Keita; Araki, Motoo; Ohno, Yoshio; Fujita, Kazutoshi; Takahara, Kiyoshi; Komura, Kazumasa; Inamoto, Teruo; Azuma, Haruhito; Kimura, Takahiro
Discordance between PSA level and bone metastatic volume is associated with unfavourable prognosis

PSA水平与骨转移体积之间的不一致与不良预后相关

BJU INTERNATIONAL
IF4.4
2025-11-010
PRE
Shirafuji, Tomoki; Yamada, Yasutaka; Sato, Kodai; Xue, Zhao; Tsujino, Takuya; Saito, Shinpei; Maenosono, Ryoichi; Nishimura, Kazuki; Fukushima, Tatsuo; Nakamura, Ko; Yamamoto, Satoshi; Arai, Takayuki; Sato, Hiroaki; Higuchi, Kosuke; Takei, Akinori; Kanesaka, Manato; Ando, Keisuke; Pae, Sangjon; Kanaoka, Sanji; Takeshita, Nobushige; Yoneda, Kei; Hino, Daichi; Tamura, Takaaki; Sazuka, Tomokazu; Imamura, Yusuke; Fujimura, Masaaki; Mikami, Kazuo; Nakamura, Kazuyoshi; Fukasawa, Satoshi; Kurozumi, Akira; Naya, Yukio; Nagata, Maki; Komaru, Atsushi; Tobe, Toyofusa; Suzuki, Noriyuki; Azuma, Haruhito; Sakamoto, Shinichi
Prognostic impact of lung metastasis in patients treated with androgen receptor signaling inhibitors for castration-sensitive prostate cancer: data from the ULTRA-Japan Consortium

去势敏感型前列腺癌患者接受雄激素受体信号抑制剂治疗后肺转移的预后影响: 来自超日本财团的数据

JAPANESE JOURNAL OF CLINICAL ONCOLOGY
IF2.2
2025-10-010
PRE
Uchimoto, Taizo; Hirosuna, Kensuke; Niigawa, Heima; Kakumae, Sho; Morinaka, Hirofumi; Fukuokaya, Wataru; Yoshizawa, Atsuhiko; Saruta, Masanobu; Fujimoto, Saizo; Morita, Tsuyoshi; Yamamoto, Yutaka; Sakamoto, Moritoshi; Nishimura, Kazuki; Maenosono, Ryoichi; Tsujino, Takuya; Nishio, Kyosuke; Yoshikawa, Yuki; Ichihashi, Atsushi; Yamamoto, Shutaro; Iwatani, Kosuke; Urabe, Fumihiko; Mori, Keiichiro; Yanagisawa, Takafumi; Tsuduki, Shunsuke; Takahara, Kiyoshi; Inamoto, Teruo; Fujita, Kazutoshi; Azuma, Haruhito; Kimura, Takahiro; Komura, Kazumasa
Deciphering RCC immunotherapy outcomes: insights from a Japanese multi-institutional study on the CANLPH score's impact

解读RCC免疫治疗效果：日本多机构研究关于CANLPH评分影响的见解

WORLD JOURNAL OF UROLOGY
IF2.9
2025-02-241
PRE
Fukushima, Tatsuo; Tsujino, Takuya; Sakamoto, Moritoshi; Takahara, Kiyoshi; Komura, Kazumasa; Yanagisawa, Takafumi; Mori, Keiichiro; Fukuokaya, Wataru; Urabe, Fumihiko; Adachi, Takahiro; Hirasawa, Yosuke; Saruta, Masanobu; Yoshizawa, Atsuhiko; Toyoda, Shingo; Kawada, Tatsushi; Katayama, Satoshi; Iwatsuki, Kengo; Nakamura, Ko; Nishio, Kyosuke; Nishimura, Kazuki; Nakamori, Keita; Matsunaga, Tomohisa; Maenosono, Ryoichi; Uchimoto, Taizo; Takai, Tomoaki; Hashimoto, Takeshi; Inamoto, Teruo; Fujita, Kazutoshi; Araki, Motoo; Ohno, Yoshio; Shiroki, Ryoichi; Azuma, Haruhito
Mechanistic insights into lethal hyper progressive disease induced by PD-L1 inhibitor in metastatic urothelial carcinoma
NPJ PRECISION ONCOLOGY
IF8
2024-09-170
OAAI
Nishimura, Kazuki; Takahara, Kiyoshi; Komura, Kazumasa; Ishida, Mitsuaki; Hirosuna, Kensuke; Maenosono, Ryoichi; Ajiro, Masahiko; Sakamoto, Moritoshi; Iwatsuki, Kengo; Nakajima, Yuki; Tsujino, Takuya; Taniguchi, Kohei; Tanaka, Tomohito; Inamoto, Teruo; Hirose, Yoshinobu; Ono, Fumihito; Kondo, Yoichi; Yoshimi, Akihide; Azuma, Haruhito
C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma
TARGETED ONCOLOGY
IF4
2024-05-285
PRE
Uchimoto, Taizo; Matsuda, Takuya; Komura, Kazumasa; Fukuokaya, Wataru; Adachi, Takahiro; Hirasawa, Yosuke; Hashimoto, Takeshi; Yoshizawa, Atsuhiko; Saruta, Masanobu; Hashimoto, Mamoru; Higashio, Takuya; Tsuchida, Shuya; Nishimura, Kazuki; Tsujino, Takuya; Nakamura, Ko; Fukushima, Tatsuo; Nishio, Kyosuke; Yamamoto, Shutaro; Iwatani, Kosuke; Urabe, Fumihiko; Mori, Keiichiro; Yanagisawa, Takafumi; Tsuduki, Shunsuke; Takahara, Kiyoshi; Inamoto, Teruo; Miki, Jun; Fujita, Kazutoshi; Kimura, Takahiro; Ohno, Yoshio; Shiroki, Ryoichi; Uemura, Hirotsugu; Azuma, Haruhito
Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint Inhibitors
TARGETED ONCOLOGY
IF4
2024-03-285
PRE
Uchimoto, Taizo; Tsuchida, Shuya; Komura, Kazumasa; Fukuokaya, Wataru; Adachi, Takahiro; Hirasawa, Yosuke; Hashimoto, Takeshi; Yoshizawa, Atsuhiko; Saruta, Masanobu; Hashimoto, Mamoru; Higashio, Takuya; Matsuda, Takuya; Nishimura, Kazuki; Tsujino, Takuya; Nakamura, Ko; Fukushima, Tatsuo; Nishio, Kyosuke; Yamamoto, Shutaro; Iwatani, Kosuke; Urabe, Fumihiko; Mori, Keiichiro; Yanagisawa, Takafumi; Tsuduki, Shunsuke; Takahara, Kiyoshi; Inamoto, Teruo; Miki, Jun; Fujita, Kazutoshi; Kimura, Takahiro; Ohno, Yoshio; Shiroki, Ryoichi; Uemura, Hirotsugu; Azuma, Haruhito
The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer
MOLECULAR CANCER
IF33.9
2023-11-1811
OAAI
Komura, Kazumasa; Hirosuna, Kensuke; Tokushige, Satoshi; Tsujino, Takuya; Nishimura, Kazuki; Ishida, Mitsuaki; Hayashi, Takuo; Ura, Ayako; Ohno, Takaya; Yamazaki, Shogo; Nakamori, Keita; Kinoshita, Shoko; Maenosono, Ryoichi; Ajiro, Masahiko; Yoshikawa, Yuki; Takai, Tomoaki; Tsutsumi, Takeshi; Taniguchi, Kohei; Tanaka, Tomohito; Takahara, Kiyoshi; Konuma, Tsuyoshi; Inamoto, Teruo; Hirose, Yoshinobu; Ono, Fumihito; Shiraishi, Yuichi; Yoshimi, Akihide; Azuma, Haruhito
Re-challenging chemotherapy after pembrolizumab in platinum-refractory urothelial carcinoma

pembrolizumab治疗铂难治性尿路上皮癌后的重新挑战化疗

BJU INTERNATIONAL
IF4.4
2022-09-269
PRE
Uchimoto, Taizo; Fukushima, Tatsuo; Komura, Kazumasa; Fukuokaya, Wataru; Adachi, Takahiro; Hashimoto, Takeshi; Yoshizawa, Atsuhiko; Nakamura, Ko; Yano, Yusuke; Nishimura, Kazuki; Nishio, Kyosuke; Nakamori, Keita; Iwatani, Kosuke; Yamamoto, Shutaro; Urabe, Fumihiko; Mori, Keiichiro; Yanagisawa, Takafumi; Tsuduki, Shunsuke; Takahara, Kiyoshi; Inamoto, Teruo; Miki, Jun; Kimura, Takahiro; Ohno, Yoshio; Shiroki, Ryoichi; Egawa, Shin; Azuma, Haruhito
Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer
JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2022-01-1713
OAAI
Nishimura, Kazuki; Nishio, Kyosuke; Hirosuna, Kensuke; Komura, Kazumasa; Hayashi, Takuo; Fukuokaya, Wataru; Ura, Ayako; Uchimoto, Taizo; Nakamura, Ko; Fukushima, Tatsuo; Yano, Yusuke; Takahashi, Nobushige; Nakamori, Keita; Kinoshita, Shoko; Matsunaga, Tomohisa; Tsutsumi, Takeshi; Tsujino, Takuya; Taniguchi, Kohei; Tanaka, Tomohito; Uehara, Hirofumi; Takahara, Kiyoshi; Inamoto, Teruo; Hirose, Yoshinobu; Kimura, Takahiro; Egawa, Shin; Azuma, Haruhito
Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents
ONCOGENE
IF7.3
2021-09-2023
OAAI
Komura, Kazumasa; Inamoto, Teruo; Tsujino, Takuya; Matsui, Yusuke; Konuma, Tsuyoshi; Nishimura, Kazuki; Uchimoto, Taizo; Tsutsumi, Takeshi; Matsunaga, Tomohisa; Maenosono, Ryoichi; Yoshikawa, Yuki; Taniguchi, Kohei; Tanaka, Tomohito; Uehara, Hirofumi; Hirata, Koichi; Hirano, Hajime; Nomi, Hayahito; Hirose, Yoshinobu; Ono, Fumihito; Azuma, Haruhito

研究方向

暂未获取到该数据
H
Haruhito Azuma
H 指数:48论文数:461被引数:7,870
K
Kazumasa Komura
H 指数:25论文数:254被引数:2,345
T
Takuya Tsujino
H 指数:28论文数:163被引数:2,813
T
Teruo Inamoto
H 指数:29论文数:268被引数:3,106
T
Taizo Uchimoto
H 指数:15论文数:62被引数:580
K
Kiyoshi Takahara
H 指数:23论文数:217被引数:1,872
R
Ryoichi Maenosono
H 指数:15论文数:75被引数:684
W
Wataru Fukuokaya
H 指数:17论文数:154被引数:1,077
K
Kyosuke Nishio
H 指数:11论文数:87被引数:400
F
Fumihiko Urabe
H 指数:18论文数:263被引数:2,130